Insider Transactions Report for Beta Bionics, Inc.

Adam Lezack, a director at Beta Bionics, Inc. (BBNX), reported several transactions on May 21-22, 2026. On May 21, Lezack sold 1,000 shares of Common Stock at $9.95 per share, pursuant to a Rule 10b5-1 Plan, leaving him with 11,432 shares. On the same day, he acquired 16,965 shares of Common Stock at no cost, representing a restricted stock unit award, bringing his total to 28,397 shares. On May 22, Lezack sold an additional 998 shares of Common Stock at $11.21 per share, also under the Rule 10b5-1 Plan, resulting in 27,399 shares held. The reporting owner is Adam Lezack, with CIK 0002048466. The filing was signed by Stephen Feider, Attorney-in-Fact, on May 26, 2026.